Stockchase Opinions

John Zechner Sprint Nextel S-N DON'T BUY Aug 17, 2012

Has had a pretty substantial move so far this year. Clearly the fundamentals have improved. Pricing is more favourable and margins are starting to improve again. Has been a good story and has turned around but he would like to see if they can maintain that for a couple of quarters in a more competitive environment.

$5.190

Stock price when the opinion was issued

Telecommunications
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

DON'T BUY

Just delivered an ugly quarter: missed and lowered guidance. It's deeply unprofitable. Sold off 35% today.

PAST TOP PICK
(A Top Pick Aug 03/22, Down 45%)

Is the #2 cybersecurity stock in detention and response. Their problem is they compete with Crowdstrike, #1.

WATCH

An up-and-comer, has received some Upgrades. Prefers to FTNT.

RISKY

One cybersecurity name to buy if you're willing to tolerate a bit more risk. Competes with CRWD.

TOP PICK

Not in the same league as CRWD based on market cap. But closest you can come to a CRWD product. He's not saying it will be an acquisition, but it will have challenges with scale, as everyone's knocking on their door. Buy here around $23, again around $20, and the final third around $18. 12-month price target of $25. Reports August 30. No dividend.

(Analysts’ price target is $25.47)
BUY

One of the leaders in the space. 

PARTIAL BUY

Benefited a lot from the CRWD issue, and probably the closest competitor of CRWD. Its software can do a security fix on data and access right away. Now around $27, 12-month price target of $29.90. Getting up there, but he'd still buy 1/3 here, add again around $26.25, final 1/3 around $25.

HOLD

Caters more to larger enterprises. A bit pricey to add right now.

BUY

Like the teenager in the room in the cybersecurity space. Very big into identity assessment.

HOLD
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

EPS of 4c beat estimates of 1.2c; revenue of $225M beat estimates of $222M. Still, F2026 forecast was lowered: to sales $1.01B from estimates $1.03B. Margins to 78.5% from 79.3%. Q1 sales to $228M from $235.6M estimated. Most brokers re-iterated their ratings. It was a decent Q4, but a less-than-ideal forecast is always going to hit a stock trading at 105X earnings. We do not think it is a time for panic, and the company will see its first proft this fiscal year (ends January 31). But in this market, we think buyers can wait: we would give it a HOLD.
Unlock Premium - Try 5i Free